- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06921356
Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes (DASH-Life)
March 23, 2026 updated by: Johns Hopkins University
Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes Residing in Urban Food Deserts (DASH-Life): Pilot Randomized Clinical Trial
People with high blood pressure and diabetes often have low levels of key nutrients as a result of not eating enough fresh fruits and vegetables.
Research studies suggest that these nutrients can lower blood pressure and blood sugar.
This study will investigate if providing encouragement to adopt this healthy and nutritious way of eating and providing guidance on weight management will lower blood pressure and blood sugar.
The DASH-Life research study will recruit adults with hypertension and type 2 diabetes who live in Baltimore metro areas that don't have many stores selling healthy foods.
The DASH-Life research study is 6 months long.
Participants will be randomly assigned to one of two groups: 1) Self-Shopping DASH (S-DASH) diet advice group, or 2) Coaching DASH (C-DASH) diet advice group.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jessica Yeh, PhD
- Phone Number: 410-614-4316
- Email: hyeh1@jhmi.edu
Study Contact Backup
- Name: Letitia Thomas
- Phone Number: 410-281-1600
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21207
- Recruiting
- Johns Hopkins ProHealth Clinical Research Unit
-
Contact:
- Letitia Thomas
- Phone Number: 410-281-1600
- Email: lthomas7@jhmi.edu
-
Principal Investigator:
- Jessica Yeh, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 years or older
- Diabetes Mellitus Type 2 defined by: self-reported type 2 diabetes diagnosis, or HbA1c>=6.5%, or treatment of diabetes with diabetes medications(s)
- Baseline systolic BP 120-159 mmHg (with or without medications.)
- Serum potassium level >3.0 and <5 mmol/L,
- Estimated glomerular filtration rate (eGFR) >=45 mL/min/1.73m2.
- Willing and able to complete required procedures in English.
- Living in Healthy Food Priority Area in Baltimore; the US Department of Agriculture (USDA) defined low income, low access areas, or census blocks with area deprivation index (ADI) 60 and above (State Decile>=6.)
Exclusion Criteria:
- Hypoglycemia requiring hospitalization or the assistance of another person in the last 6 months
- Cardiovascular event within 6 months
- On diabetes or weight loss medications such as glucagon-like peptide 1 (GLP-1), GLP-1/glucose-dependent insulin-releasing peptide (GIP), insulin, or any combination of these medications
- HbA1c ≥ 10%
- Type 1 diabetes
- Baseline systolic BP < 100 mmHg
- Weight >400 lbs due to the maximum weight on study scale
- Chronic disease that might interfere with trial participation
- Current participation in another clinical trial that might affect blood pressure, weight loss, diabetes, or ability to adhere to study procedures
- Current participation in program with conflicting dietary guidance (i.e., meal replacement or keto diets)
- Unwillingness or inability to adopt a DASH-like diet
- Planning to leave area in the next 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Self-Shopping DASH diet advice group (S-DASH)
|
Participants assigned to the S-DASH group will receive a brochure about the DASH eating plan.
For the first three months, Participants will also receive a gift card to shop at a local supermarket.
During months 4-6, participants will be asked to continue following the DASH eating plan listed in the brochure but will no longer be provided the grocery gift card.
|
|
Experimental: Coach-Directed Tailored DASH Groceries Plus Lifestyle Intervention (C-DASH)
|
Participants assigned to the C-DASH group will meet by telephone with the study coach for 1 hour, and then have brief weekly conversations (about 15-30 minutes) by phone during the first three months.
During these weekly calls, the study coach will assist participant with selecting fruits, vegetables, nuts, and beans.
During months 4-6, the study coach will continue to work with participant to set goals for following the DASH-Life way of eating, but the study will no longer provide a weekly food allowance to purchase groceries.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility as assessed by the number of participants enrolled
Time Frame: Baseline
|
The observed count of responses to the prescreening will be summarized.
Recruitment yields at screening visit and randomization visit will be derived.
|
Baseline
|
|
Acceptability as assessed by the Acceptability of the Intervention Measure survey
Time Frame: 3 months
|
Acceptability of the intervention will be quantitatively measured by the Acceptability of Intervention Measure (AIM) survey.
The survey consists of 4 items, each measured on a 5-point Likert scale from 1 (completely disagree) to 5 (completely agree).
The score is calculated as the mean of the responses to the 4 items.
A higher score is better.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jessica Yeh, PhD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
June 30, 2027
Study Registration Dates
First Submitted
March 31, 2025
First Submitted That Met QC Criteria
April 8, 2025
First Posted (Actual)
April 10, 2025
Study Record Updates
Last Update Posted (Actual)
March 24, 2026
Last Update Submitted That Met QC Criteria
March 23, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00425074
- P50MD017348 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Self-Shopping DASH diet advice
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Beth Israel Deaconess Medical CenterUniversity of Vermont; American Heart AssociationRecruitingCardiovascular Diseases | Hypertension | Dietary Intervention | Elevated Blood PressureUnited States
-
Beth Israel Deaconess Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruiting
-
Beth Israel Deaconess Medical CenterAmerican Heart AssociationActive, not recruitingHypertension | Elevated Blood PressureUnited States
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
Columbia UniversityCompleted
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Nutrisystem, Inc.Biofortis Clinical Research, Inc.CompletedWeight Loss | Overweight and Obesity
-
Case Western Reserve UniversityCompleted
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus